Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Emma Smith

Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.
Showing 12 out of 73 results
GP appointment patient

GPs don’t have an easy task spotting cancer. Read about our work to support them and the public in spotting the potential signs of cancer earlier. GPs don’t have an easy task spotting cancer. Read about our work to support them and the public in spotting the potential signs of cancer earlier.

by Emma Smith | Analysis | 10 February 2014

10 February 2014

Neuroblastoma is a type of childhood cancer and our researchers are pioneering new clinical trials to tackle aggressive forms of the disease - how does it work? Neuroblastoma is a type of childhood cancer and our researchers are pioneering new clinical trials to tackle aggressive forms of the disease - how does it work?

by Emma Smith | Analysis | 13 August 2013

13 August 2013

The latest in Our Milestones series: the story of tamoxifen, a discovery in 1966 that has gone on to save the lives of millions of women with breast cancer. The latest in Our Milestones series: the story of tamoxifen, a discovery in 1966 that has gone on to save the lives of millions of women with breast cancer.

by Emma Smith | Analysis | 15 October 2012

15 October 2012

This entry is part 12 of 30 in the series Our milestones